Publisher
Springer Science and Business Media LLC
Subject
Psychiatry and Mental health,Pharmacology
Reference51 articles.
1. Abdul-Ridha A, Lane JR, Mistry SN, Lopez L, Sexton PM, Scammells PJ et al (2014). Mechanistic insights into allosteric structure-function relationships at the M1 muscarinic acetylcholine receptor. J Biol Chem 289: 33701–33711.
2. Barakat A, Dean B, Scarr E, Evin G (2010). Decreased Neuregulin 1 C-terminal fragment in Brodmann's area 6 of patients with schizophrenia. Schizophr Res 124: 200–207.
3. Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A et al (1997). Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol 54: 465–473.
4. Boyson SJ, McGonigle P, Luthin GR, Wolfe BB, Molinoff PB (1988). Effects of chronic administration of neuroleptic and anticholinergic agents on densities of D2 dopamine and muscarinic cholinergic receptors in rat striatum. J Pharmacol Exp Ther 244: 987–993.
5. Bymaster FP, Felder C, Ahmed S, McKinzie D (2002). Muscarinic receptors as a target for drugs treating schizophrenia. Curr Drug Tar CNS Neurolog Dis 1: 163–181.
Cited by
26 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献